Day: October 9, 2020

ANDOVER, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) announced today it will hold its third quarter 2020 earnings conference call and webcast on Thursday, October 22, 2020 at 5:00 p.m. (Eastern). Prepared remarks regarding the company’s financial and operational results for the three and nine months ended September 30, 2020 will be followed by a question and answer period with Patrizio Vinciarelli, Chief Executive Officer, and James A. Simms, Chief Financial Officer.Results for the third quarter will be released over GlobeNewswire at the close of the NASDAQ Market Session on October 22, 2020, and the press release and a summary of the company’s financial statements will be available shortly thereafter on the Investor Relations page of Vicor’s website.Vicor encourages investors and analysts...

Aegion Leaders and Industry Experts will Discuss the Critical State of America’s Aging Infrastructure, Current Funding Dynamics and Crucial Steps Needed to Bridge the Long-Term Investment Gap for Repairs and RehabilitationST. LOUIS, Oct. 09, 2020 (GLOBE NEWSWIRE) — Aegion Corporation (NASDAQ:AEGN) and its subsidiary, Insituform Technologies, today announced that they will host “Water/Wastewater Infrastructure Funding: Considerations for Today & Tomorrow to Address the Nation’s Critical Investment Gap,” a complimentary webinar presented by Trenchless Technology Magazine that is scheduled for October 14 at 2:00 p.m. ET.Most of America’s water and wastewater infrastructure is either nearing the end of its useful life or is in a current state of disrepair. Billions of dollars are spent each year to rehabilitate, replace, expand...

Worcester, MA, Oct. 09, 2020 (GLOBE NEWSWIRE) — Vystar® Corporation (OTCQB: VYST) paid off more than $2 million in debt since July 1, 2020, including paying off multiple notes and lines of credit in September 2020, and consolidating other debt as it enters the peak retail holiday shopping season and the fourth quarter with its RxAir® UV-C Light air purifier line and Rotmans’ home furnishings poised to fill urgent needs amid the COVID-19 pandemic. The debts were satisfied as follows (full details in 8K SEC filing):Libertas Funding LLC — On February 24, 2020, Vystar and Rotmans had entered into an agreement with Libertas Funding LLC to sell future receipts totaling $1,089,000 for a purchase price of $825,000. The Libertas funding has been paid off with no further obligation.New Debt Obligation – The Company entered into...

Results demonstrate a greater than 65% mean reduction in proteinuria at week 48 in C3G patients treated with pegcetacoplanSustained improvements were seen across key clinical measures at 48 weeksThere are no approved medicines for C3G, a rare disease that often leads to kidney failureWALTHAM, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that positive results from the Phase 2 DISCOVERY study evaluating pegcetacoplan, a targeted C3 therapy, in patients with C3 glomerulopathy (C3G) will be presented at the American Society of Nephrology (ASN) Kidney Week on October 22, 2020. The 48-week results show that patients treated with pegcetacoplan demonstrated sustained improvements across key clinical measures including...

Boca Raton, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) — Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights for the development of IMT504, a novel, patented immunotherapy, to treat symptomatic rabies. IMT504 is being developed to treat patients whose disease has progressed beyond the stage where it can be treated by the existing approved rabies vaccines.IMT504 has been granted orphan drug designation in the US, which provides significant benefits including tax credits, market exclusivity and waiver of certain FDA fees. Rabies is one of only 14 diseases which qualify for the FDA Tropical...

West Palm Beach, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) — USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, is proud to announce today, that its common stock was approved for quotation on the OTC Markets Group, Inc.’s OTCQB® tier Venture Market (the “OTCQB”).“Up listing to the OTCQB Venture Market tier is an important milestone in USA Equities Corp’s current and future plans,” stated Troy Grogan, CEO. “We believe that the wider market exposure afforded by the OTCQB will increase our visibility within the investment community and assist in broadening our institutional shareholder base.”“Our overall focus is on enhancing diagnostics and evidence based remote monitoring capability of physicians while building a solid and profitable digital medicine, virtual...

GLEN BURNIE, Md., Oct. 09, 2020 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (NASDAQ: GLBZ), parent company of The Bank of Glen Burnie®, announced that its Board of Directors declared a regular dividend of ten cents ($0.10) per share of common stock at their meeting on October 8, 2020. This action marks the company’s 113th consecutive dividend.The regular dividend is payable on November 2, 2020 to shareholders of record at the close of business on October 19, 2020.Glen Burnie Bancorp, parent company to The Bank of Glen Burnie, currently maintains consolidated assets totaling $430.9 million at September 30, 2020. Founded in 1949, The Bank of Glen Burnie is a community bank with eight branch offices serving Anne Arundel County, MD (www.thebankofglenburnie.com).Certain information contained in this news release, which does not relate to...

SOUTH JORDAN, Utah, Oct. 09, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the third fiscal quarter ended September 30, 2020, after the close of the stock market on Wednesday, October 28, 2020. The Company also announced plans to host an investor call after the close of the stock market on Tuesday, November 10, 2020.Management will host an investor conference call on Wednesday, October 28, 2020 at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific) to discuss the results of the quarter and provide a corporate update with a question-and-answer session. Those who would like...